Defence Therapeutics's total assets for Q2 2024 were C$668.85K, a decrease of -57.88% from the previous quarter. DTCFF total liabilities were C$2.96M for the fiscal quarter, a 46.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.